AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
+0.0020 (100.00%)
Jan 22, 2025, 2:45 PM EST
AXIM Biotechnologies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -4.14 | -8.06 | -6.24 | -16.03 | -6.41 | -6.45 | Upgrade
|
| Depreciation & Amortization | 0.43 | 0.43 | 0.43 | 2.12 | 0.02 | 0 | Upgrade
|
| Other Amortization | 0.22 | 0.22 | 0.39 | 0.71 | 0.34 | 0.19 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 5.97 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.21 | -0.38 | Upgrade
|
| Stock-Based Compensation | 0.17 | 0.28 | 1.19 | 3.13 | 2.31 | 1.84 | Upgrade
|
| Other Operating Activities | 1.25 | 4.81 | 1.16 | 1.65 | 1.04 | 3.42 | Upgrade
|
| Change in Inventory | - | - | 0.02 | -0.02 | - | - | Upgrade
|
| Change in Accounts Payable | 0.72 | 0.77 | 0.66 | 0.28 | 0.53 | 0.15 | Upgrade
|
| Change in Unearned Revenue | -0.09 | -0.03 | 0.33 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 0.67 | 0.55 | 0.03 | -0.29 | -0.05 | -0.13 | Upgrade
|
| Operating Cash Flow | -0.76 | -1.03 | -2.04 | -2.49 | -3.22 | -5.04 | Upgrade
|
| Capital Expenditures | -0 | - | -0.01 | -0.04 | -0.1 | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | 0.08 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.01 | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | - | 0.38 | Upgrade
|
| Other Investing Activities | - | - | - | - | 0.03 | -0.03 | Upgrade
|
| Investing Cash Flow | -0 | - | -0.01 | -0.05 | 0.01 | 0.35 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 0.01 | - | 0.02 | Upgrade
|
| Long-Term Debt Issued | - | 0.68 | 1.33 | 1.01 | - | - | Upgrade
|
| Total Debt Issued | 0.3 | 0.68 | 1.33 | 1.02 | - | 0.02 | Upgrade
|
| Short-Term Debt Repaid | - | -0.03 | -0.09 | -0.12 | -0.09 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -1.33 | - | - | -0.01 | Upgrade
|
| Total Debt Repaid | - | -0.03 | -1.42 | -0.12 | -0.09 | -0.01 | Upgrade
|
| Net Debt Issued (Repaid) | 0.3 | 0.65 | -0.09 | 0.9 | -0.09 | 0.01 | Upgrade
|
| Issuance of Common Stock | 0.37 | 0.49 | 1.74 | 1.64 | 3.31 | 3.46 | Upgrade
|
| Other Financing Activities | - | - | - | - | -0.07 | -0.08 | Upgrade
|
| Financing Cash Flow | 0.67 | 1.14 | 1.65 | 2.53 | 3.15 | 3.4 | Upgrade
|
| Net Cash Flow | -0.09 | 0.11 | -0.41 | -0 | -0.05 | -1.29 | Upgrade
|
| Free Cash Flow | -0.76 | -1.03 | -2.05 | -2.53 | -3.31 | -5.04 | Upgrade
|
| Free Cash Flow Margin | -820.08% | -2607.67% | -23132.80% | -4180.05% | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.03 | -0.08 | Upgrade
|
| Cash Interest Paid | - | - | 0.18 | - | - | 0.06 | Upgrade
|
| Levered Free Cash Flow | -3 | 0.97 | 0.48 | 0.51 | -2.35 | 1.77 | Upgrade
|
| Unlevered Free Cash Flow | -2.73 | 1.54 | 1.47 | 0.48 | -2.23 | 1.88 | Upgrade
|
| Change in Net Working Capital | 1.81 | -2.59 | -2.56 | 0.09 | 1.62 | -1.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.